28.01.2021 • News

Polynt-Reichhold Up for Sale

The private equity owners of Polynt-Reichhold are seeking a sale of the specialty chemicals company, according to Reuters. Sources told the news agency that the value of any deal would likely be about €2.5 billion. An agreement is expected in the second quarter of this year.

Polynt-Reichhold was formed in 2017 from merging Polynt, owned by Italian buyout fund Investindustrial, with Reichhold, owned by US asset management firm Black Diamond Capital Management. The composites and resins producer has 40 manufacturing facilities worldwide and annual revenues of about €2 billion. It has three regional headquarters in located in Scanzorosciate, Italy (Polynt’s historical HQ); Carpentersville, Illinois, USA and Changzhou, China. 

Investindustrial is said to have picked Morgan Stanley to work on the sale, with the process due to start in the coming weeks. Reuters quoted an anonymous source as saying that the sale is going to “draw interest not just from industry names but private equity with the know-how and skills like Cinven or Apollo.”

Last September, Investindustrial and Black Diamond agreed to buy Hexion’s phenolic specialty resin, hexamine and European forest products resins businesses for about $425 million. The deal is due to close during the current quarter.

Author: Elaine Burridge, Freelance Journalist

The private equity owners of Polynt-Reichhold are seeking a sale of the...
The private equity owners of Polynt-Reichhold are seeking a sale of the specialty chemicals company, according to Reuters news agency. Sources said the value of any deal will likely be about €2.5 billion. An agreement is expected in the second quarter of this year. (c) Miguel Á.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.